• Importing medicine from Canada's or other countries' drug supplies isn't safe or cost-effective.

  • More than a decade into the counterfeit pill crisis, fake prescription pills made with deadly ingredients are still killing Americans. 

  • Overwhelming demand for transformative GLP-1s has led to widespread illicit compounding and a boom in counterfeiting.

  • Several states are trying to to set price caps to reduce the cost of expensive medicine, but this could bankrupt pharmacies and threaten patient access.

Fishy Peptide Freight: What Q1 2026 import data reveals

June 9, 2026

As the popularity of peptides skyrockets, consumers should be asking questions about where their drugs come from. Here’s what we found in shipment data for peptides in Q1.

June 8, 2026: Reckless physicians prescribing experimental, black market weight loss drugs: “Why are we waiting?”

June 9, 2026

Retatrutide, an experimental weight loss drug that hasn’t been submitted for FDA-approval, is being prescribed in weight loss clinics and med spas across the country.

Prescription Drug Freight Fraud Report, March–April 2026

June 9, 2026

March and April 2026 saw thousands of shipments of drugs imported into the US, including weight loss drugs and antibiotics. We studied these shipments to learn more about their manufacturers and contents.

Fake medicines in Mexico, November 2025 – May 2026

June 5, 2026

Americans buying prescription medicines in Mexico are overlooking widespread drug counterfeiting in the country, and as AFPs popularize medical tourism to lower costs, what happens in Mexico’s drug supply chain is even more of a problem for Americans.

June 1, 2026: Up to 18 years for counterfeit pill conspirators in Massachusetts

June 2, 2026

The scheme, which produced counterfeit oxycodone, Adderall, and Xanax, is linked to over a dozen deaths, according to prosecutors.

May 26, 2026: Maryland PDAB passes a price cap on Ozempic, as Virginia’s governor questions board efficacy

May 27, 2026

Ozempic, the second drug that the state has set an upper payment limit on, will be capped at $274 for a 30-day supply.

May 18, 2026: FDA warns 503B compounding pharmacy for producing tirzepatide after shortage ended

May 19, 2026

The ProRx warning letter signals increased FDA scrutiny of compounded weight loss product that are not intended to be compounded in the US.

Like your information on video? Subscribe to our YouTube playlist!

youtube-video-thumbnail

How're smugglers getting peptides into the country?  

youtube-video-thumbnail

14 were arrested in connection with a nationwide counterfeit drug operation.

youtube-video-thumbnail

A recent FDA warning letter highlights upstream supply chain vulnerabilities.

Click the images below to see more recent videos.